Dr. Fauci shifts the timeline on when the general public will be able to get a vaccine

Dr. Anthony Fauci said vaccines won’t be available to the “general public” before mid- to late May or early June, he told CNN’s Jim Sciutto on Tuesday.

Fauci, director of the National Institute of Allergy and Infectious Diseases, acknowledged that previous estimates had placed vaccine availability for the general public – or nonessential workers under 65 with no health conditions – closer to the end of April.

“If you start talking about when the vaccine would be more widely available to the general population, I was hoping that that would be by the end of April, namely, have gone through all the priorities and now say, OK anyone can get it,” Fauci said. “That was predicated on J&J, the Johnson product, having considerably more doses than now we know they’re going to have.”

Johnson & Johnson will have fewer than 10 million vaccine doses available if the US Food and Drug Administration authorizes it for emergency use in the coming weeks, a federal health official told CNN earlier this month.

“So, that timeline will probably be prolonged, maybe into mid- to late May and early June, that’s fine,” Fauci said.

He downplayed the shifted expectations and noted that there will be several months between when vaccinations are generally available and when each person will individually be able to access one.

“You can say, let’s say in May, vaccines are going to be widely available to almost anybody May, June, but it may take to June, July and August to finally get everyone vaccinated,” he said. “So when you hear about how long it’s going to take to get the overwhelming population vaccinated, I don’t think anybody disagrees that that’s going to be well to the end of the summer and we get in the early fall.”

- Source: CNN " data-fave-thumbnails="{"big": { "uri": "https://media.cnn.com/api/v1/images/stellar/prod/210216120015-acuitas-therapeutics-lipid-nanoparticle.jpg?q=x_0,y_0,h_1080,w_1919,c_fill/h_540,w_960" }, "small": { "uri": "https://media.cnn.com/api/v1/images/stellar/prod/210216120015-acuitas-therapeutics-lipid-nanoparticle.jpg?q=x_0,y_0,h_1080,w_1919,c_fill/h_540,w_960" } }" data-vr-video="false" data-show-html="" data-byline-html="

" data-timestamp-html="

Updated 2:04 AM EST, Wed February 17, 2021

" data-check-event-based-preview="" data-is-vertical-video-embed="false" data-network-id="" data-publish-date="2021-02-16T12:23:34Z" data-video-section="business" data-canonical-url="https://www.cnn.com/videos/business/2021/02/16/coronavirus-vaccine-production-challenges-stewart-pkg-intl-ldn-vpx.cnn" data-branding-key="" data-video-slug="coronavirus vaccine production challenges Stewart pkg intl ldn vpx" data-first-publish-slug="coronavirus vaccine production challenges Stewart pkg intl ldn vpx" data-video-tags="communicable disease control,coronavirus,diseases and disorders,health and medical,infectious diseases,life forms,microscopic life,public health,vaccination and immunization,viruses" data-details="">

Video Ad Feedback

This 'critical' component for Covid-19 vaccines is in short supply

03:12 - Source: CNN

Fauci’s comments come as the US on Monday reported more than 53,800 new Covid-19 infections: its lowest daily case count since October and a vastly different number from those plaguing the country just last month, when infections were topping 200,000 a day.

Statistics across the US are now reflecting more encouraging trends. California, one of the states hit hardest by the pandemic, reported its lowest daily case increase since early November.

In Illinois, Chicago has seen its “lowest test positivity rate … since our COVID outbreak started,” according to Dr. Allison Arwady, commissioner for the Chicago Department of Public Health.

That comes amid a steady decline not only in new infections but also in hospitalizations as well.

Why cases and hospitalizations are dropping

The sharp drop in cases is due to a combination of the end of the post-holiday surge, increased preventive measures like masks and distancing and the tens of millions of previously infected people who now have a level of natural immunity.

Vaccines, too, are increasingly going into arms and limiting the virus’s ability to find new hosts. The US has administered more than 55 million vaccine doses so far and is averaging about 1.7 million doses administered every day, a number that has been steadily increasing.

“It’s hard to know, but I do think that one possibility is you’re starting to see the first evidence of herd immunity,” said Dr. Paul Offit, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia.

NEW YORK, NY - DECEMBER 23: A woman wearing a face shield and a mask rides the uptown subway December 23, 2020 in New York City. Subway ridership is down nearly 70% from 2019 due to the COVID-19 pandemic. (Photo by Robert Nickelsberg/Getty Images)

Related article Here's why some Covid-19 numbers keep improving. (Hint: It's not widespread vaccinations)

Meanwhile, President Joe Biden’s administration is again increasing its weekly Covid-19 vaccine supply being sent to states, White House press secretary Jen Psaki announced Tuesday.

During a call with governors, White House Covid-19 coordinator Jeff Zients informed the officials that the administration is “increasing the vaccine supply to 13.5 million doses per week to states,” Psaki said at Tuesday’s briefing, a 57% increase from inauguration levels.

Additionally, Psaki said, the administration will be “doubling the supply to our pharmacy program.” This week, there will be 2 million doses sent to pharmacies across the country, she said, which is expected to expand in the coming weeks.

Even as the Covid-19 data is heading in the right direction, tens of thousands of people continue to become newly infected with the virus every day. And experts worry that if Americans let their guards down – especially now with variants circulating – there could be another surge coming.

“The only thing that I’m concerned about now, is that we do have this UK variant … and it seems to be accelerating in the United States,” Dr. Peter Hotez, dean for the National School for Tropical Medicine at the Baylor College of Medicine, told CNN on Monday.

CDC data shows more than 1,100 cases of the highly contagious B.1.1.7 variant – first detected in the UK – have been reported in the US. The agency has previously warned the strain will see rapid growth in early 2021 and will likely become the predominant variant by March.

“I think we should be assuming that the next wave of case growth, to the extent that we have it, is going to be with B.1.1.7, and that’s something that I think everybody has to be even more cautious about,” Andy Slavitt, White House Covid-19 senior adviser, said on MSNBC on Monday. “It’s nice to see the numbers of cases drop, but it could be misleading.”

It’s important to avoid giving Covid-19 the opportunity to mutate, and it can change even if much of the population is vaccinated, said Dr. Michael Mina, an epidemiologist and immunologist at the Harvard T.H. Chan School of Public Health.

“The best thing we could possibly do to improve the chances that the vaccine will continue working, as we’re hoping it will, is to reduce cases as much as possible without having those reductions occur as a result of vaccine-derived immunity,” Mina said during an event hosted by Harvard on Tuesday.

On a positive note, the mutations aren’t escaping detection by the tests currently used, Mina added.

“Very few, if any, are significantly impacted by the variants,” he said.

Mitigation measures, like masks, distancing and testing, will continue to play a key role even as more people become vaccinated, according to Mina.

“Those can help preserve the vaccine by reducing the numbers of cases that are coming in contact with people who have been vaccinated. The more opportunities we give the virus to come in contact with somebody who is immune, the more opportunities there are for the virus to find a way around that level of immunity and those antibodies.”

Frigid weather causes vaccine delays

And while officials are working to get more Americans vaccinated, winter storms are now delaying the process in parts of the country.

In Texas, Dallas County officials announced they were closing the Fair Park vaccination site through Wednesday because of severe weather.

A truck drives past a highway sign Monday, Feb. 15, 2021, in Houston. A frigid blast of winter weather across the U.S. plunged Texas into an unusually icy emergency Monday that knocked out power to more than 2 million people and shut down grocery stores and dangerously snowy roads. (AP Photo/David J. Phillip)

Related article Cities and states delay Covid-19 vaccine distribution because of winter storms

“We understand the urgency to administer second doses of the vaccine, but we must also balance people’s safety,” officials said in a news release. “As soon as we can safely open again, we will.”

Missouri Gov. Mike Parson said mass vaccination events planned through Friday were canceled due to severe weather that “makes driving dangerous and threatens the health and safety of anyone exposed to the cold.”

In Kentucky, Gov. Andy Beshear said that while the weather “is going to slow down our vaccinations,” he hopes the state will be able to make up for the delays next week.

The storms caused disruptions as states continue to grapple with other vaccine challenges, including short supply and distribution inequities.

Georgia Gov. Brian Kemp said on Monday that while progress on vaccine hesitancy and equity among members of the Latino community was “encouraging,” the state was still seeing a “substantial disparity in vaccine administration between Hispanic and non-Hispanic communities.”

He added the state still needed more supply from the federal government to be able to meet the growing demand.

“When we get to that point when we can expand the supply and we have that supply, we need people to be comfortable taking the vaccine,” the governor said.

CNN’s Keith Allen, Maria Cartaya, Jacqueline Howard, Betsy Klein, Lauren Mascarenhas, Deidre McPhillips, Cheri Mossburg, Pete Muntean, Michael Nedelman, Yon Pomrenze, Rebekah Riess, Evan Simko-Bednarski, Elizabeth Stuart, Naomi Thomas and Amanda Watts contributed to this report.